Abstract
On December 8, 2024, the International Council of Experts was held in Moscow to discuss methods of prevention and comprehensive therapy of respiratory infectious diseases in children, including those with chronic diseases. The experts presented reports on several topical issues: the current epidemic situation of acute respiratory viral infections (ARVI) and influenza, the problem of prevention and treatment of influenza and ARVI in children, including those with allergic conditions, chronic hepatitis, and the peculiarities of the effect of respiratory viruses on immunity in children. The paper focused on the evidence base, efficacy, and safety of Cytovir-3, a drug for the prevention, etiotropic, and immunostimulating therapy of influenza and ARVI.